QUVIVIQ (daridorexant)

This product, the process of its manufacture, or its use, may be covered by one or more patents in the US and other countries, including US Patent Nos. 9,732,075; 9,790,208; and 10,023,560.

Further patents related to the active ingredient, or the process of its manufacture include US Patent Nos. 9,914,720; and 11,124,488.

TRYVIO (aprocitentan)

This product, the process of its manufacture, or its use, may be covered by one or more patents in the US and other countries, including US Patent Nos. 8,325,232; 10,919,881; 11,174,247; 11,680,058; and 11,787,782.

 

Further patents related to the active ingredient, or the process of its manufacture include US Patent No. 9,938,244.